The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of DM002, an anti-MUC1/HER3 bispecific antibody-drug conjugate, in patients with advanced solid tumors.
 
Xian Jun Yu
No Relationships to Disclose
 
Jian Zhang
No Relationships to Disclose
 
Udit Nindra
No Relationships to Disclose
 
Joe Wei
No Relationships to Disclose
 
Siqing Fu
Research Funding - Abbisko (Inst); Antengene (Inst); BeiGene (Inst); BeyondSpring Pharmaceuticals (Inst); Biotheus (Inst); Boehringer Ingelheim (Inst); Clinical and Translational Science Award Grant (CTSA) 1UM1TR0045906 (Inst); Coherent Biopharma (Inst); CPRIT Precision Oncology Decision Support Core (RP150535) (Inst); Crossignal (Inst); CUE Biopharma (Inst); DEKA Biosciences (Inst); Exelis (Inst); Exelis (Inst); Fore Biotherapeutics (Inst); Greenfire Bio (Inst); Hookipa Pharma (Inst); IMV (Inst); Innovent Biologics (Inst); Jazz Pharmaceuticals (Inst); K-Group Beta (Inst); Lantern Pharma (Inst); Lilly (Inst); Lyvgen Biopharma (Inst); MacroGenics (Inst); MediLink Therapeutics (Inst); Millennium (Inst); Nerviano Medical Sciences (Inst); NeuPharma, Inc. (Inst); NextCure (Inst); NIH/NCI (Inst); Ningbo NewBay Medical Technology (Inst); Novartis (Inst); NovoCure (Inst); Nykode Therapeutics (Inst); Parexel International, LLC (Inst); PharmaMar (Inst); Pionyr (Inst); PureTech (Inst); Qurgen Inc. (Inst); Sellas Life Sciences (Inst); Shanghai Huaota Biopharmaceutical (Inst); Soricimed (Inst); SQZ Biotech (Inst); Sumitomo Dainippon Pharma Oncology (Inst); Taiho Oncology (Inst); Tigermed Group (Inst); TransCode Therapeutics, Inc. (Inst); Treadwell Therapeutics (Inst); Turnstone Bio (Inst); Tyligand Bioscience (Inst); Virogin Biotech (Inst)
 
Ganessan Kichenadasse
No Relationships to Disclose
 
Guiling Li
No Relationships to Disclose
 
Zhisong He
No Relationships to Disclose
 
Jundong Li
No Relationships to Disclose
 
Yuanming Shen
No Relationships to Disclose
 
Xiaohua Wu
No Relationships to Disclose